(NAPSI)—Good news: According to a recent report from the American Association for Cancer Research (AACR), discoveries across basic, translational, and clinical research as well as population sciences are driving advances in cancer medicine and early detection, leading to a steady decline in the overall U.S. cancer death rate, and allowing more people to live longer and fuller lives after a cancer diagnosis.

From the AACR Cancer Progress Report 2025, here’s a look at some recent breakthroughs.

Between July 1, 2024 and June 30, 2025, the U.S. Food and Drug Administration (FDA) approved 20 new anticancer therapeutics, including:

•the first T-cell receptor (TCR) T-cell therapy, approved for patients with soft tissue sarcoma;

•a new therapeutic antibody targeting a novel protein on stomach

See Full Page